View Press Releases
-
Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology
-
Basepair™ - The Point and Click NGS Analysis & Visualization Platform Now Available in AWS Marketplace
Basepair™, The First Point and Click NGS Analysis & Visualization Platform of It's Kind is Now Available in AWS Marketplace
Sep 26, 2022
-
DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE
Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) and is installing the largest commercial platform of the Olink® technology in the Americas outside of Olink itself to become a leading global certified service provider for the Olink Proximity Extension Assay (PEA) technology, a unique anti-body based proteomic technology.
Sep 19, 2022
-
Curebase and Meru Health to Partner on Clinical Research for App-based Mental Health Treatment Program
Curebase, a company committed to democratizing access to clinical studies, today announced it is partnering with Meru Health on a three-year clinical trial to determine the effectiveness of the online mental healthcare provider’s 12-week treatment program for reducing depression among primary care patients.
Sep 19, 2022
-
VERICHEM OFFERS CLINICAL REFERENCE MATERIALS FOR THE CALIBRATION VERIFICATION TESTING OF LACTATE ASSAYS
VERICHEM LABORATORIES now offers a liquid stable and ready-to-use set of clinical reference materials for use with the clinical testing of Lactate.
Sep 18, 2022
-
Step up Research on Magnetic Metal Complexes Using Versatile Materials
-
High-Quality Dexmedetomidine Hydrochloride (API) Meeting CP & EP Standards
-
Liposomes as Drug Delivery Vehicles
-
BioIVT Launches GMP-grade VivoSTART Leukopaks for Cell and Gene Therapy Manufacturing
VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.
Sep 19, 2022
-
Integrated DNA Technologies Expands Customization Options for Alt-R™ Custom CRISPR gRNA Libraries for Drug Discovery
-
Inizio Biotech makes key leadership appointment to meet demand from emerging biotech
-
Anti-inflammatory drug candidate DMXD-011 shows efficacy in ex-vivo human studies
-
TFDA Grants CTL Amedica License to Market MATISSE™ ACIF Cage System
The Taiwan Food and Drug Administration has granted CTL Amedica Corporation a license to market the MATISSE Anterior Cervical Interbody Fusion (ACIF) Cage System.
Sep 14, 2022
-
Clinion - Platinum Sponsor for ISCR 3rd Autumn Conference 2022
-
BrightInsight Selects Lyniate to Enhance Interoperability Strategic Engagement Will Improve Information Exchange for Regulated Digital Health Solutions Built on the BrightInsight® Platform
-
Graphene Modification Helps to Unlock New Potentials
-
Accelerated Shelf-Life Testing to Assess Drug Stability
-
Four Most Commonly Used Surfactants You Should Know
-
Bora expands its CDMO capabilities as it makes landmark acquisition of TWi Pharmaceuticals
-
BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates
XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies.
Sep 11, 2022